JP7235352B1 - 唇に適用するマイクロニードルパッチ製造用組成物およびこの組成物で製造されたマイクロニードルパッチ - Google Patents
唇に適用するマイクロニードルパッチ製造用組成物およびこの組成物で製造されたマイクロニードルパッチ Download PDFInfo
- Publication number
- JP7235352B1 JP7235352B1 JP2021159530A JP2021159530A JP7235352B1 JP 7235352 B1 JP7235352 B1 JP 7235352B1 JP 2021159530 A JP2021159530 A JP 2021159530A JP 2021159530 A JP2021159530 A JP 2021159530A JP 7235352 B1 JP7235352 B1 JP 7235352B1
- Authority
- JP
- Japan
- Prior art keywords
- lips
- lip
- microneedle patch
- composition
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- 239000004480 active ingredient Substances 0.000 claims abstract description 26
- 239000000126 substance Substances 0.000 claims abstract description 26
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 20
- VLDFMKOUUQYFGF-UHFFFAOYSA-N 4-(butoxymethyl)-2-methoxyphenol Chemical compound CCCCOCC1=CC=C(O)C(OC)=C1 VLDFMKOUUQYFGF-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940078465 vanillyl butyl ether Drugs 0.000 claims abstract description 17
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 13
- 230000007794 irritation Effects 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 13
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 12
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 229960000458 allantoin Drugs 0.000 claims abstract description 10
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 9
- 230000000694 effects Effects 0.000 claims description 42
- 230000037303 wrinkles Effects 0.000 claims description 25
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 13
- 235000013793 astaxanthin Nutrition 0.000 claims description 13
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 13
- 229940022405 astaxanthin Drugs 0.000 claims description 13
- 239000001168 astaxanthin Substances 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 239000003158 myorelaxant agent Substances 0.000 claims description 5
- QGGBBQJHVCVVKM-XOBYPWAZSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-[[(2s)-1-amino-3-carboxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amin Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(N)=O QGGBBQJHVCVVKM-XOBYPWAZSA-N 0.000 claims description 4
- 239000004475 Arginine Substances 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- 229940078033 acetyl octapeptide-3 Drugs 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 229920001184 polypeptide Polymers 0.000 claims description 4
- 239000001054 red pigment Substances 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 230000036571 hydration Effects 0.000 claims description 2
- 238000006703 hydration reaction Methods 0.000 claims description 2
- 238000012360 testing method Methods 0.000 description 35
- 238000011156 evaluation Methods 0.000 description 18
- 238000000034 method Methods 0.000 description 11
- 238000005259 measurement Methods 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000008859 change Effects 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 240000004584 Tamarindus indica Species 0.000 description 2
- 235000004298 Tamarindus indica Nutrition 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 208000013602 lip disease Diseases 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 244000106483 Anogeissus latifolia Species 0.000 description 1
- 235000011514 Anogeissus latifolia Nutrition 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- SNVFDPHQAOXWJZ-UHFFFAOYSA-N Furcelleran Chemical compound CCOC(=O)C1=C(C)NC(C=2C=CC=CC=2)=C(C(=O)OCC=2C=CC=CC=2)C1C#CC1=CC=CC=C1 SNVFDPHQAOXWJZ-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000001922 Gum ghatti Substances 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 244000090599 Plantago psyllium Species 0.000 description 1
- 235000010451 Plantago psyllium Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 241000593922 Quercus acutissima Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000019314 gum ghatti Nutrition 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000007433 macroscopic evaluation Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000000615 nonconductor Substances 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000011158 quantitative evaluation Methods 0.000 description 1
- 229940108461 rennet Drugs 0.000 description 1
- 108010058314 rennet Proteins 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Description
本発明の一実施例にかかる組成物はマイクロニードル製造のためのもので、モールディング方式だけでなく送風引張方式でもマイクロニードル製造が可能でなければならない。送風引張方式を適用する場合、マイクロニードル製造のための組成物は引張によってマイクロニードルの形態を備えなければならないので、粘度が臨界値以上の粘性組成物でなければならない。
アスタキサンチンが有効成分として含まれ赤色を示すマイクロニードルの色が時間の経過につれ相対的に薄くなることから使用者はマイクロニードルに含まれた唇生気改善有効成分が唇皮膚内に吸収された事実を視覚的に確認可能となる。これは唇生気改善用マイクロニードルパッチの商品性を向上させることができる要因として理解することができる。
本発明者らは上述した表の組成物を使って送風引張方式により製造したマイクロニードルパッチを唇に適用したとき、唇じわの深さ、唇ボリューム、唇水分に対する改善効果を評価することを目的として人体適用試験を行った。唇色改善は別途の評価試験を経ずとも肉眼ですぐに確認できるため、定量的評価を主目的にする本人体適用試験では除外した。
(1)唇疾患を体験していない満20~39才成人女性
(2)試験責任者または試験責任者の委任を受けた者が試験対象者に教えなければならない事項について、十分に説明を聞いて自発的に同意書に署名した人
(3)唇および皮膚疾患を含む急・慢性身体的疾患のない健康な人
(4)試験期間中、追跡観察が可能な人
(1)唇に外傷、奇形、外科的傷跡などの異常を持つ人
(2)妊娠または授乳中の女性と妊娠計画のある女性
(3)皮膚疾患治療のためにステロイドが含まれた皮膚外用制を1ヶ月以上使った人
(4)同じ試験に参加した後6ヶ月が経過していない人
(5)敏感性、過敏性皮膚を持つ人
(6)研究開始前3ヶ月以内に試験部位に同一または類似の効能化粧品および医薬品などを使った人
(7)研究開始前6ヶ月以内に試験部位に施術を受けた人
(8)その他試験責任者の判断で試験に不向きであると考えられる人
(1)試験部位に掻痒感や紅斑などの有害事例が発生した場合
(2)試験対象者が試験期間中に試験部位に過度な紫外線露出をしたり、過度な飲酒、喫煙などの結果により、評価に障害が発生する場合
(3)試験対象者が試験期間中、個人事情によって追跡観察が難しい場合
(4)試験対象者が自発的に同意を撤回した場合
(5)その他やむを得ない理由がある場合
Claims (6)
- ヒアルロン酸またはその塩からなる生分解性基材と、唇の生気を改善する有効成分を含み、
前記有効成分は、唇にボリューム感を付与する物質としてバニリルブチルエーテル1.5重量%ないし3.0重量%と、バニリルブチルエーテルによった唇刺激を緩和する物質としてアラントイン0.1重量%ないし3.0重量%を含むことを特徴とする
唇に適用するマイクロニードルパッチ製造用組成物。 - 唇じわ改善用物質として1または2種類以上の筋肉弛緩ペプチドが前記有効成分に含まれ、前記筋肉弛緩ペプチドは、アセチルオクタペプタイド-3および/またはアルギニン/リシンポリペプチドである、請求項1記載の唇に適用するマイクロニードルパッチ製造用組成物。
- 唇色改善用物質として天然赤色色素であるアスタキサンチンが前記有効成分に含まれる、請求項2記載の唇に適用するマイクロニードルパッチ製造用組成物。
- 前記生分解性基材物質によって唇水分増加効果が達成される、請求項3記載の唇に適用するマイクロニードルパッチ製造用組成物。
- 請求項1~4のいずれか1項に記載の組成物で製造された、唇に適用するマイクロニードルパッチ。
- 前記マイクロニードルパッチが唇に適用されて時間が経過するにつれ前記有効成分中の一つであるアスタキサンチンによるマイクロニードルの赤色が薄くなり、これにより有効成分の唇皮膚内吸収程度に対する認知が可能になる、請求項5記載の唇に適用するマイクロニードルパッチ。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021159530A JP7235352B1 (ja) | 2021-09-29 | 2021-09-29 | 唇に適用するマイクロニードルパッチ製造用組成物およびこの組成物で製造されたマイクロニードルパッチ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021159530A JP7235352B1 (ja) | 2021-09-29 | 2021-09-29 | 唇に適用するマイクロニードルパッチ製造用組成物およびこの組成物で製造されたマイクロニードルパッチ |
Publications (2)
Publication Number | Publication Date |
---|---|
JP7235352B1 true JP7235352B1 (ja) | 2023-03-08 |
JP2023049658A JP2023049658A (ja) | 2023-04-10 |
Family
ID=85475707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021159530A Active JP7235352B1 (ja) | 2021-09-29 | 2021-09-29 | 唇に適用するマイクロニードルパッチ製造用組成物およびこの組成物で製造されたマイクロニードルパッチ |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7235352B1 (ja) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101565495B1 (ko) | 2014-09-16 | 2015-11-04 | 김상인 | 입술 색상의 지속 효과를 가지는 입술 화장료 조성물 및 그의 제조방법 |
WO2019087654A1 (ja) | 2017-11-02 | 2019-05-09 | Nissha株式会社 | マイクロニードルシート及びその製造方法 |
KR101996673B1 (ko) | 2019-03-06 | 2019-07-04 | 주식회사 루벨리 | 마스크팩 및 안면 밴드를 포함하는 피부탄력 개선용 패키지 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101272740B1 (ko) * | 2006-06-30 | 2013-06-10 | (주)아모레퍼시픽 | 립플럼핑 효과를 주는 입술용 화장료 조성물 |
CN110769891A (zh) * | 2017-08-17 | 2020-02-07 | 考司美德制药株式会社 | 口唇用微针阵列 |
-
2021
- 2021-09-29 JP JP2021159530A patent/JP7235352B1/ja active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101565495B1 (ko) | 2014-09-16 | 2015-11-04 | 김상인 | 입술 색상의 지속 효과를 가지는 입술 화장료 조성물 및 그의 제조방법 |
WO2019087654A1 (ja) | 2017-11-02 | 2019-05-09 | Nissha株式会社 | マイクロニードルシート及びその製造方法 |
KR101996673B1 (ko) | 2019-03-06 | 2019-07-04 | 주식회사 루벨리 | 마스크팩 및 안면 밴드를 포함하는 피부탄력 개선용 패키지 |
Non-Patent Citations (1)
Title |
---|
FRAGRANCE JOURNAL,2020年,Vol.12,pp.41-48 |
Also Published As
Publication number | Publication date |
---|---|
JP2023049658A (ja) | 2023-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11234921B2 (en) | Moisturizing compositions and uses thereof | |
TWI660744B (zh) | 一組四維保濕組合及其在製備保濕化妝品的應用 | |
TWI312687B (en) | Skin lotion and wrinkle improving agent | |
US11026907B2 (en) | Azelaic acid gel, preparation method and application thereof | |
WO2014044808A2 (en) | Fast-penetration cosmetic dermal filler for topical application | |
AU2018237198B2 (en) | Botulinum neurotoxins for use in therapy | |
CN105687045A (zh) | 一种气垫bb霜及其制备方法 | |
CN105687059A (zh) | 一种用于抗衰老的化妆品组合物及其配制方法、应用 | |
JP7235352B1 (ja) | 唇に適用するマイクロニードルパッチ製造用組成物およびこの組成物で製造されたマイクロニードルパッチ | |
CN104188859B (zh) | 一种含天然成分提取物的抗皱嫩肤乳液及其制备方法 | |
CN108721154A (zh) | 一种用于皮肤保湿和屏障修复的护肤品及其制备方法 | |
CN105581921A (zh) | 一种用于肌肤修复的护肤液 | |
WO2022153337A1 (en) | A nutraceuticals formulation with an enhanced organoleptic properties used for skin care | |
CN105287496B (zh) | 一种治疗鱼鳞病的药物组合物及其制备方法 | |
CN110464676A (zh) | 活性成分包括γ-聚谷氨酸的化妆品组合物 | |
JP2007008912A (ja) | 生活リズム恒常性維持のための美容施術方法 | |
TWI823549B (zh) | 褐藻水萃取物用於製備抗藍光的皮膚外用產品之用途 | |
BR112018074893B1 (pt) | Composição cosmética antissinais, uso da composição e dispositivo de aplicação | |
CN107998017A (zh) | 一种含有桂花提取物的祛皱、亮肤组合物及其制备方法 | |
Ha et al. | Anti-wrinkle Effects of Mixed Extracts of Three Medicinal Herbs | |
Tanuwidjaja | Development of Anti-Aging Cream Preparations with Active Substances from Plant Extracts: Physicochemical Review and Potential Applications | |
CN106074285A (zh) | 一种具有补水美白祛痘功能的化妆品 | |
CN105434303A (zh) | 一种祛皱组合物及其皮肤外用制剂和该组合物的应用 | |
JP2024504628A (ja) | カンナビジオール及びブロッコリー種子油を含有する組成物、並びにそのような組成物の作製方法及び使用方法 | |
JP2024519837A (ja) | スキンケアの方法及び製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210929 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221018 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230117 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230207 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230216 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7235352 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |